Impact of cranial and axillary/subclavian artery involvement by color duplex sonography on response to treatment in giant cell arteritis

Journal of Vascular Surgery

Volumn 61, Issue 5, 2015, Pages 1285-1291

  Czihal, Michael ^a   Piller, Anne ^a   Schroettle, Angelika ^a   Kuhlencordt, Peter ^a   Bernau, Christoph ^a   Schulze Koops, Hendrik ^a   Hoffmann, Ulrich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; ETANERCEPT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLATE MOFETIL; PREDNISOLONE; RITUXIMAB; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

AGED; AORTA ANEURYSM; AORTA VALVE REGURGITATION; ARTICLE; ATRIAL FIBRILLATION; AXILLARY ARTERY; BRAIN ISCHEMIA; CARDIAC PATIENT; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SUBCLAVIAN ARTERY; TEMPORAL ARTERY; TREATMENT RESPONSE; VASCULITIS; CAROTID ARTERY; COHORT ANALYSIS; COLOR ULTRASOUND FLOWMETRY; DOSE RESPONSE; DRUG EFFECTS; MIDDLE AGED;

ADRENAL CORTEX HORMONES; AGED; AXILLARY ARTERY; CAROTID ARTERIES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GIANT CELL ARTERITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; SUBCLAVIAN ARTERY; TEMPORAL ARTERIES; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84929027603     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.12.045     Document Type: Article

References (31)

1. J.C. Jennette, R.J. Falk, P.A. Bacon, N. Basu, M.C. Cid, F. Ferrario et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Arthritis Rheum 65 2013 1 11
2. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients Arthritis Rheum 55 2006 131 137
3. W.A. Schmidt, A. Seifert, E. Gromnica-Ihle, A. Krause, and A. Natusch Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis Rheumatology (Oxford) 47 2008 96 101
4. C. Agard, J.H. Barrier, B. Dupas, T. Ponge, A. Mahr, G. Fradet et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan Arthritis Rheum 59 2008 670 676
5. M. Aschwanden, F. Kesten, M. Stern, C. Thalhammer, U.A. Walker, A. Tyndall et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2×11 arterial regions Ann Rheum Dis 69 2010 1356 1359
6. S. Förster, F. Tato, M. Weiss, M. Czihal, A. Rominger, P. Bartenstein et al. Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET Vasa 40 2011 219 227
7. A. Ghinoi, N. Pipitone, A. Nicolini, L. Boiardi, M. Silingardi, G. Germanò et al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study Rheumatology (Oxford) 51 2012 730 734
8. M. Czihal, S. Zanker, A. Rademacher, F. Tatò, P.J. Kuhlencordt, H. Schulze-Koops et al. Sonographic and clinical pattern of extracranial and cranial giant cell arteritis Scand J Rheumatol 41 2012 231 236
9. S. Prieto-González, P. Arguis, A. García-Martínez, G. Espígol-Frigolé, I. Tavera-Bahillo, M. Butjosa et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography Ann Rheum Dis 71 2012 1170 1176
10. P.C. Grayson, K. Maksimowicz-McKinnon, T.M. Clark, G. Tomasson, D. Cuthbertson, S. Carette et al. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis Ann Rheum Dis 71 2012 1329 1334
11. G.S. Hoffman, M.C. Cid, D.B. Hellmann, L. Guillevin, J.H. Stone, J. Schousboe et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis Arthritis Rheum 46 2002 1309 1318
12. G.S. Hoffman, M.C. Cid, D.B. Hellmann, L. Guillevin, J.H. Stone, J. Schousboe et al. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial Ann Intern Med 146 2007 621 630
13. J.A. Jover, C. Hernández-García, I.C. Morado, E. Vargas, A. Bañares, and B. Fernández-Gutiérrez Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial Ann Intern Med 134 2001 106 114
14. V.M. Martínez-Taboada, V. Rodríguez-Valverde, L. Carreño, J. López-Longo, M. Figueroa, J. Belzunegui et al. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects Ann Rheum Dis 67 2008 625 630
15. M. Mazlumzadeh, G.G. Hunder, K.A. Easley, K.T. Calamia, E.L. Matteson, W.L. Griffing et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial Arthritis Rheum 54 2006 3310 3318
16. A. Proven, S.E. Gabriel, C. Orces, W.M. O'Fallon, and G.G. Hunder Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes Arthritis Rheum 49 2003 703 708
17. J. Hernández-Rodríguez, A. García-Martínez, J. Casademont, X. Filella, M.J. Esteban, A. López-Soto et al. A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis Arthritis Rheum 47 2002 29 35
18. G.G. Hunder, D.A. Bloch, B.A. Michel, M.B. Stevens, W.P. Arend, L.H. Calabrese et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis Arthritis Rheum 33 1990 1122 1128
19. W.A. Schmidt, H.E. Kraft, K. Vorpahl, L. Völker, and E.J. Gromnica-Ihle Color duplex ultrasonography in the diagnosis of temporal arteritis N Engl J Med 337 1997 1336 1342
20. F. Tatò, and U. Hoffmann Giant cell arteritis: a systemic vascular disease Vasc Med 13 2008 127 140
21. A.D. Mahr, J.A. Jover, R.F. Spiera, C. Hernández-García, B. Fernández-Gutiérrez, M.P. Lavalley et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis Arthritis Rheum 56 2007 2789 2797
22. G. Nesher, R. Nesher, M. Mates, M. Sonnenblick, and G.S. Breuer Giant cell arteritis: intensity of the initial systemic inflammatory response and the course of the disease Clin Exp Rheumatol 26 3 Suppl 49 2008 30 34
23. L. Martinez-Lado, C. Calviño-Díaz, A. Piñeiro, T. Dierssen, T.R. Vazquez-Rodriguez, J.A. Miranda-Filloy et al. Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain Medicine (Baltimore) 90 2011 186 193
24. C.M. Weyand, J.W. Fulbright, G.G. Hunder, J.M. Evans, and J.J. Goronzy Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity Arthritis Rheum 43 2000 1041 1048
25. A. García-Martínez, J. Hernández-Rodríguez, G. Espígol-Frigolé, S. Prieto-González, M. Butjosa, M. Segarra et al. Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis Arthritis Care Res (Hoboken) 62 2010 835 841
26. M. Both, K. Ahmadi-Simab, M. Reuter, O. Dourvos, E. Fritzer, S. Ullrich et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis Ann Rheum Dis 67 2008 1030 1033
27. O. Espitia, A. Néel, C. Leux, J. Connault, A. Espitia-Thibault, T. Ponge et al. Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with longterm followup J Rheumatol 39 2012 2157 2162
28. W.A. Schmidt Ultrasound in vasculitis Clin Exp Rheumatol 32 1 Suppl 80 2014 71 77
29. A. Arida, M. Kyprianou, M. Kanakis, and P.P. Sfikakis The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis BMC Musculoskelet Disord 11 2010 44
30. F. Tatò, and U. Hoffmann Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases J Vasc Surg 44 2006 176 182
31. M. Czihal, F. Tatò, A. Rademacher, P. Kuhlencordt, H. Schulze-Koops, and U. Hoffmann Involvement of the femoropopliteal arteries in giant cell arteritis: clinical and color duplex sonography J Rheumatol 39 2012 314 321